Morpho Partners With IntegenX To Offer Rapid DNA Identification Technology

morphotrak

Morpho (Safran), the world leader in biometric solutions, is joining with IntegenX, the market leader in rapid DNA technology, to offer DNA identification solutions providing DNA profiles in approximately 90 minutes. Morpho will partner with IntegenX to market its RapidHIT® System to law enforcement and government agencies in select countries around the world.

Based on a breakthrough technology, the RapidHIT is a fully automated system that generates DNA profiles from reference samples. It can be used in laboratories, police stations, or directly at the crime scene. The RapidHIT System is the first rapid DNA technology to use an FBI-approved chemistry, enabling the upload of DNA profiles to the National DNA Index System (NDIS)*.

For the past three decades, Morpho has been providing criminal identification solutions to law enforcement and government agencies around the world. Under this partnership, Morpho will leverage its world leadership in biometrics (Automated Biometric Identification Systems and booking stations) and its global presence to offer DNA solutions and support services.

By adding DNA to its biometric technology portfolio, Morpho will deliver powerful solutions capable of accelerating investigations, particularly during the custody period.

“IntegenX is committed to bringing Rapid DNA testing to the forefront of our communities,” stated Robert Schueren, President, Chief Executive Officer of IntegenX. “We are excited by the capabilities brought forward through our partnership with Morpho.”

“Our customers around the world look to us for the most innovative and efficient criminal investigation solutions,” commented Philippe Petitcolin, Chairman and Chief Executive Officer of Morpho. “We are proud to collaborate with IntegenX to introduce rapid DNA identification to speed up crime solving in the field.”

* NDIS: Contains the DNA profiles contributed by federal, state, and local participating forensic laboratories.

Source: morpho.com
0 Comments